Patient experiences and unmet needs in diagnosis and treatment of metastatic colorectal cancer: results of a US survey.
10 affiliations
- 1Colorectal Cancer Alliance, Washington, DC, USA.
- 2COLONTOWN, Crownsville, MD, USA.
- 3BLKHLTH, Atlanta, GA, USA.
- 4Family Reach, Boston, MA, USA.
- 5The Harris Poll, Chicago, IL, USA.
- 6Vanderbilt University Medical Center, Nashville, TN, USA.
- 7Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA, USA.
- 8Takeda Pharmaceuticals U.S.A., Inc., Cambridge, MA, USA.
- 9Advent Health Cancer Institute, Orlando, FL, USA.
- 10Weill Cornell Medicine and New York Presbyterian, New York, NY, USA.
Abstract
Background
Metastatic colorectal cancer (mCRC) can impact patients beyond their physical health. We conducted a survey to evaluate patient perspectives on care and treatment experience.Methods
The survey was conducted by The Harris Poll in the United States. Adults with mCRC were recruited via online panels and patient advocacy groups. Sampling precision was measured via a Bayesian credible interval; data were accurate to within 5.3% points (95% confidence level).Results
Of the 344 respondents, 46% identified as non-Hispanic White, 25% as non-Hispanic Black/African American, and 22% as Hispanic; the mean age was 56 years. Overall, 31% reported that their mCRC diagnosis was delayed, with 83% wishing more information had been provided by their health-care provider at diagnosis. Mental health resources were difficult to access for 53% of the respondents and 88% experienced financial impacts because of their mCRC diagnosis. Furthermore, 49% reported negative impacts from health inequities affecting their care. Overall, 67% of the respondents wished for more power in treatment decision-making.Conclusions
The survey highlights key unmet medical and non-medical patient needs in mCRC care. Access to informational resources, including for financial assistance, and a greater emphasis on shared treatment decision-making would help patients feel valued and improve their mCRC experience.
Related
- Recorrido y barreras en el acceso a diagnóstico y tratamiento de la enfermedad de Chagas en Argentina: un mapa desde la experiencia de las personas The journey and barriers to accessing diagnosis and treatment for Chagas disease in Argentina: a patient journey map based on people’s experiences Percurso e barreiras no acesso ao diagnóstico e ao tratamento da doença de Chagas na Argentina: um panorama a partir de experiências pessoais
- Survival Outcomes in Metastatic Colorectal Cancer Patients with BRAF Mutations Undergoing Targeted Chemotherapy: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials.
- Diagnosis and management of prediabetes and early type 2 diabetes: a qualitative study of patient experiences
- Patient experiences of benzodiazepine tapering: a qualitative study of treatment in addiction care.
- A Contemporary Review of Resectability and Treatment Strategies for Colorectal Liver Metastases: Part 1—Diagnosis, Defining Resectability, and Management of Upfront Resectable and Synchronous Disease
BibTeX
@article{newcomer2026patient,
title = {{Patient experiences and unmet needs in diagnosis and treatment of metastatic colorectal cancer: results of a US survey.}},
author = {Kim Newcomer and Julie Clauer and Khadijah Ameen and Andrea Incudine and Amy Mulvey and Kathy Steinberg and Jeneth Aquino and Ashley Geiger and Scott Campbell and Ashley Calabrese and Mohamedtaki Tejani and Manish Shah},
journal = {Future oncology (London, England)},
year = {2026},
month = aug,
doi = {10.1080/14796694.2026.2695213},
url = {https://europepmc.org/article/MED/42858024},
note = {CC BY},
}
RIS
TY - JOUR
TI - Patient experiences and unmet needs in diagnosis and treatment of metastatic colorectal cancer: results of a US survey.
AU - Kim Newcomer
AU - Julie Clauer
AU - Khadijah Ameen
AU - Andrea Incudine
AU - Amy Mulvey
AU - Kathy Steinberg
AU - Jeneth Aquino
AU - Ashley Geiger
AU - Scott Campbell
AU - Ashley Calabrese
AU - Mohamedtaki Tejani
AU - Manish Shah
PY - 2026
DA - 2026/08/01
JO - Future oncology (London, England)
DO - 10.1080/14796694.2026.2695213
UR - https://europepmc.org/article/MED/42858024
AB - Background Metastatic colorectal cancer (mCRC) can impact patients beyond their physical health. We conducted a survey to evaluate patient perspectives on care and treatment experience.Methods The survey was conducted by The Harris Poll in the United States. Adults with mCRC were recruited via online panels and patient advocacy groups. Sampling precision was measured via a Bayesian credible interval; data were accurate to within 5.3% points (95% confidence level).Results Of the 344 respondents, 46% identified as non-Hispanic White, 25% as non-Hispanic Black/African American, and 22% as Hispanic; the mean age was 56 years. Overall, 31% reported that their mCRC diagnosis was delayed, with 83% wishing more information had been provided by their health-care provider at diagnosis. Mental health resources were difficult to access for 53% of the respondents and 88% experienced financial impacts because of their mCRC diagnosis. Furthermore, 49% reported negative impacts from health inequities affecting their care. Overall, 67% of the respondents wished for more power in treatment decision-making.Conclusions The survey highlights key unmet medical and non-medical patient needs in mCRC care. Access to informational resources, including for financial assistance, and a greater emphasis on shared treatment decision-making would help patients feel valued and improve their mCRC experience.
SN - 1479-6694
SN - 1744-8301
ER -